Accepted Version (2.566Mb)
British Journal of Pharmacology. Accepted Version 2017: DOI: 10.1111/bph.13889 Big conductance calcium-activated potassium channel openers control spasticity without sedation David Baker1,2*, Gareth Pryce1,2*, Cristina Visintin2,3, Sofia Sisay1, Alexander I. Bondarenko4,5, W.S. Vanessa Ho6, Samuel J. Jackson1, Thomas E. Williams1, Sarah Al-Izki1, Ioanna Sevastou3, Masahiro Okuyama3, Wolfgang F. Graier4, Lesley A. Stevenson6, Carolyn. Tanner7, Ruth Ross7, Roger G. Pertwee7, Christopher M. Henstridge8, Andrew J. Irving8, Jesse Schulman9, Keith Powell9, Mark D. Baker1, Gavin Giovannoni1,2 and David L. Selwood3* 1. Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, E1 2AT, United Kingdom 2. Department of Neuroinflammation, UCL Institute of Neurology, University College London, London WC1N 3BG, UK. 3. Department of Medicinal Chemistry, UCL Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, UK. 4. Institute of Molecular Biology and Biochemistry, Medical University of Graz, A-8010, Austria. 5. A.A. Bogomoletz Institute of Physiology, Kiev 01024, Ukraine. 6. Vascular Biology Research Centre. St. George’s, University of London, SW17 ORE, UK. 7. Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK. 8. Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. 9. Canbex Therapeutics Ltd, London BioScience Innovation Centre, London NW1 0NH, UK. *These authors contributed equally to the work Running title: BKCa channels control spasticity Correspondence: Prof. David Baker. Neuroimmunology Unit, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, Whitechapel, London E1 4AT, United Kingdom.
[Show full text]